Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
MEI Pharma (MEIP)
NASDAQ:MEIP
MEI Pharma (MEIP) Stock Price & Analysis
957 Followers
MEIP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.00 - $13.60
Previous Close$7.5
Volume21.70K
Average Volume (3M)76.05K
Market Cap
$49.97M
Enterprise Value-$49.01M
Total Cash (Recent Filing)$112.04M
Total Debt (Recent Filing)$13.05M
Price to Earnings (P/E)-1.3
Beta0.99
Next Earnings
Aug 31, 2023EPS Estimate
-$2.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.69
Shares Outstanding333,143
10 Day Avg. Volume103,451
30 Day Avg. Volume76,046
Standard Deviation0.21
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.07
Price to Sales (P/S)8.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.83
Enterprise Value/Gross Profit-1.20
Enterprise Value/Ebitda1.43
Forecast
1Y Price Target
$45.00Price Target Upside500.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
MEI Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MEIP FAQ
What was MEI Pharma’s price range in the past 12 months?
MEI Pharma lowest stock price was $4.00 and its highest was $13.60 in the past 12 months.
What is MEI Pharma’s market cap?
Currently, no data Available
When is MEI Pharma’s upcoming earnings report date?
MEI Pharma’s upcoming earnings report date is Aug 31, 2023 which is in 88 days.
How were MEI Pharma’s earnings last quarter?
MEI Pharma released its earnings results on May 11, 2023. The company reported -$2.32 earnings per share for the quarter, beating the consensus estimate of -$2.9 by $0.58.
Is MEI Pharma overvalued?
According to Wall Street analysts MEI Pharma’s price is currently Undervalued.
Does MEI Pharma pay dividends?
MEI Pharma does not currently pay dividends.
What is MEI Pharma’s EPS estimate?
MEI Pharma’s EPS estimate is -$2.8.
How many shares outstanding does MEI Pharma have?
MEI Pharma has 6,662,857 shares outstanding.
What happened to MEI Pharma’s price movement after its last earnings report?
MEI Pharma reported an EPS of -$2.32 in its last earnings report, beating expectations of -$2.9. Following the earnings report the stock price went up 0.575%.
Which hedge fund is a major shareholder of MEI Pharma?
Among the largest hedge funds holding MEI Pharma’s share is Carlson Capital LP. It holds MEI Pharma’s shares valued at 287K.
---
MEI Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$45.00 (500.00% Upside)
$45.00 (500.00% Upside)
Hedge Fund Trend
Increased
By 1.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $17.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.12%
12-Months-Change
Fundamentals
Return on Equity
-74.14%
Trailing 12-Months
Asset Growth
-30.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MEI Pharma
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding MEIP
iShares Core S&P Total U.S. Stock Market ETF
$67.95
Up to five ETFs with an Outperform Smart Score that hold MEIP. The ETFs are listed according to market value of MEIP within the ETF
---
---